The Motley Fool··Jonathan PoncianoCormorant's $64M Arcellx Exit Preceded 77% Gilead Takeover Surge
Cormorant Asset Management exited its $63.63M Arcellx stake in Q4, missing an 80% year-to-date rally capped by Gilead Sciences' $7.8B acquisition announcement.
GILDACLXfund exitoncology